Microbiology: In-Depth Focus 2016
Posted: 30 June 2016 | European Pharmaceutical Review | No comments yet
In this Microbiology In-Depth Focus: Risk-based microbiological testing; Improving microbiological assurance for bioburden testing; Microbiology Roundtable…
- Risk-based microbiological testing
David Elder and Paul Newby, GlaxoSmithKline - Improving microbiological assurance for bioburden testing
Tim Sandle, Bio Products Laboratory - Application Note
By Wickham Labs - Expert View
Contributed by TSI Incorporated - Microbiology Roundtable
With Rich Quashne, WW Group Marketing Manager, Industrial Microbiology at BD and Alan Hoffmeister, Global Field Technical Manager at Charles River Microbial Solutions
This Microbiology In-Depth Focus is restricted - login or subscribe free to access
Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- bi-monthly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
Issue
Related topics
Related organisations
BD Biosciences, Bio Products Laboratory, Charles River, Eppendorf, Eurofins, GlaxoSmithKline (GSK), TSI Inc., Wickham Laboratories
Related people
Alan Hoffmeister, David Elder, Paul Newby, Rich Quashne, Tim Sandle
